Web research boosts patients' confidence

13 March 2006

A study of cancer patients' behavior carried out by the Philadelphia, USA-based, Temple University, has con-cluded that newly diagnosed patients who use the Internet to research their disease and possible treatments have a more positive outlook, as well as being more active par-ticipants in their treatment. The research appears in the March issue of the Journal of Health Communication.

Sarah Bass, the principal investigator and professor of Public Health at Temple University said: "this is the first study to look at the relationship between Internet use and patient behaviors." She added, "we wanted to see if access to readily available information about their condition helped patients to cope with issues such as hair loss and other treatment side effects."

Internet-user patients: partners not subjects

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight